Can SARS-CoV-2 Infection Exacerbate Alzheimer’s Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms
Open Access
- 2 January 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (1), 29
- https://doi.org/10.3390/jpm12010029
Abstract
The current coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2, is affecting every aspect of global society, including public healthcare systems, medical care access, and the economy. Although the respiratory tract is primarily affected by SARS-CoV-2, emerging evidence suggests that the virus may also reach the central nervous system (CNS), leading to several neurological issues. In particular, people with a diagnosis of Alzheimer’s disease (AD) are a vulnerable group at high risk of contracting COVID-19, and develop more severe forms and worse outcomes, including death. Therefore, understanding shared links between COVID-19 and AD could aid the development of therapeutic strategies against both. Herein, we reviewed common risk factors and potential pathogenetic mechanisms that might contribute to the acceleration of neurodegenerative processes in AD patients infected by SARS-CoV-2.Keywords
This publication has 135 references indexed in Scilit:
- Oxidative Stress and the Pathogenesis of Alzheimer's DiseaseOxidative Medicine and Cellular Longevity, 2013
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Inflammation, microglia, and alzheimer's diseaseNeurobiology of Disease, 2010
- The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial PeptidePLOS ONE, 2010
- ApoE isoform-dependent changes in hippocampal synaptic functionMolecular Neurodegeneration, 2009
- Neuronal calcium mishandling and the pathogenesis of Alzheimer's diseaseTrends in Neurosciences, 2008
- Linking Calcium to Aβ and Alzheimer's DiseaseNeuron, 2008
- Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 2008
- Learning modulation by endogenous hippocampal IL‐1: Blockade of endogenous IL‐1 facilitates memory formationHippocampus, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002